Number of the records: 1  

The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities

  1. 1.
    SYSNO ASEP0565126
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleThe Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities
    Author(s) Rašková, M. (CZ)
    Lacina, L. (CZ)
    Kejík, Z. (CZ)
    Venhauerová, P. (CZ)
    Skaličková, S. (CZ)
    Kolář, Michal (UMG-J) RID, ORCID
    Jakůbek, M. (CZ)
    Rosel, D. (CZ)
    Smetana Jr., K. (CZ)
    Brabek, J. (CZ)
    Number of authors10
    Article number3698
    Source TitleCells. - : MDPI
    Roč. 11, č. 22 (2022)
    Number of pages23 s.
    Publication formOnline - E
    Languageeng - English
    CountryCZ - Czech Republic
    Keywordsil-6 ; cancer ; metastasis
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryCell biology
    R&D ProjectsLX22NPO5102 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    EF16_019/0000785 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LM2018131 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Research InfrastructureEATRIS-CZ III - 90133 - Univerzita Palackého v Olomouci
    Method of publishingOpen access
    Institutional supportUMG-J - RVO:68378050
    UT WOS000887160100001
    DOI10.3390/cells11223698
    AnnotationInterleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-kappa B) is an intensively studied approach in preclinical cancer research. It is of significant translational potential, numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2023
    Electronic addresshttps://www.mdpi.com/2073-4409/11/22/3698
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.